Factors affecting the value of diffusion-weighted imaging for identifying breast cancer patients with pathological complete response on neoadjuvant systemic therapy: a systematic review.

An observed trend within studies, where residual DCIS is explicitly not allowed in the pCR-definition, is that some tumors with a relative low ADC tend to have a higher chance to show pCR on NST (Fig. 5 , category: “Invasive-, DCIS-”).

also in 504 other papers